Safety and efficacy of rectal resection of robot using da Vinci Xi surgical system for cStage 0-2 rectal cancer.

Safety and efficacy of rectal resection of robot using da Vinci Xi surgical system for cStage 0-2 rectal cancer. - Study on robot-assisted rectal resection in Tokyo Metropolitan Tama Medical Center.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039575

Enrollment

Registered

2020-03-01

Start date

2019-12-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Interventions

robot-assisted surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rectal cancer,PS 0-1,BMI less than 30,No uncontrolled complications

Exclusion criteria

Exclusion criteria: Active double cancer, pregnant or lactating women, severe complications, ongoing steroid treatment

Design outcomes

Primary

Measure	Time frame
Intraoperative and postoperative adverse events associated with surgery	—

Secondary

Measure	Time frame
Completion rate of robot-assisted surgery	—

Countries

Japan

Contacts

Public ContactItaru Osaka

Tokyo Metropolitan Tama Medical Center department of surgery

itaru_osaka@tmhp.jp042-323-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026